← All companies
REPLIGEN CORP
RGEN - CIK 0000730272
Market cap$7.38 B
Rank#1121
SEC filings1,331
The table below shows REPLIGEN CORP's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $566.02M | $757.36M | $751.32M | $523.46M | $603.81M | $717.29M |
| Short-term investments | $201.61M | - | - | - | - | - |
| Receivables | $158.59M | $134.12M | $124.16M | $116.25M | $117.42M | $71.26M |
| Inventory | $170.46M | $142.96M | $202.32M | $238.28M | $184.49M | $95.03M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.